Osaic Holdings
EVH icon

Osaic Holdings’s Evolent Health EVH Stock Holding History

Osaic Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.6K Sell
14,309
-11,553
-45% -$44.3K ﹤0.01% 5141
2026
Q1 		$59K Buy
25,862
+14,502
+128% +$46K ﹤0.01% 5081
2025
Q4 		$45.4K Buy
11,360
+505
+5% +$2.81K ﹤0.01% 5299
2025
Q3 		$104K Sell
10,855
-264
-2% -$2.56K ﹤0.01% 4740
2025
Q2 		$125K Buy
11,119
+5,537
+99% +$50.9K ﹤0.01% 4324
2025
Q1 		$52.9K Sell
5,582
-327
-6% -$3.3K ﹤0.01% 4674
2024
Q4 		$66.5K Buy
5,909
+4,943
+512% +$86.9K ﹤0.01% 4487
2024
Q3 		$27.3K Sell
966
-324
-25% -$8.35K ﹤0.01% 5164
2024
Q2 		$24.7K Sell
1,290
-7,035
-85% -$180K ﹤0.01% 5189
2024
Q1 		$273K Sell
8,325
-109
-1% -$3.48K ﹤0.01% 3417
2023
Q4 		$274K Buy
8,434
+3,745
+80% +$106K ﹤0.01% 3672
2023
Q3 		$128K Buy
4,689
+2,049
+78% +$57K ﹤0.01% 4320
2023
Q2 		$80K Sell
2,640
-2,188
-45% -$70.7K ﹤0.01% 4609
2023
Q1 		$157K Buy
4,828
+1,063
+28% +$33.6K ﹤0.01% 4065
2022
Q4 		$105K Sell
3,765
-1,669
-31% -$47.8K ﹤0.01% 4391
2022
Q3 		$196K Sell
5,434
-23,542
-81% -$829K ﹤0.01% 3768
2022
Q2 		$889K Sell
28,976
-1,078
-4% -$31.4K ﹤0.01% 2392
2022
Q1 		$994K Buy
30,054
+25,999
+641% +$681K ﹤0.01% 2587
2021
Q4 		$113K Buy
4,055
+1,135
+39% +$32.6K ﹤0.01% 4491
2021
Q3 		$90K Sell
2,920
-10
-0.3% -$240 ﹤0.01% 4623
2021
Q2 		$61K Sell
2,930
-720
-20% -$14.4K ﹤0.01% 4891
2021
Q1 		$76K Sell
3,650
-2,043
-36% -$38.9K ﹤0.01% 4562
2020
Q4 		$92K Buy
5,693
+362
+7% +$4.79K ﹤0.01% 4108
2020
Q3 		$67K Buy
5,331
+2,575
+93% +$30.3K ﹤0.01% 4100
2020
Q2 		$20K Sell
2,756
-6,910
-71% -$46.3K ﹤0.01% 4793
2020
Q1 		$53K Buy
+9,666
New +$86.3K ﹤0.01% 3928

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Osaic Holdings's EVH Position: Q2 2026 in Review

Osaic Holdings reduced its Evolent Health (EVH) stake by 45% in Q2 2026, selling an estimated $44.3K and leaving 14,309 shares worth $77.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5141.

Osaic Holdings first reported a position in EVH in Q1 2020 and has held it in 26 quarters since. The position peaked at $994K in Q1 2022. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Osaic Holdings held 14,309 shares of Evolent Health worth $77.6K as of Q2 2026.
  • Osaic Holdings sold 11,553 Evolent Health shares in Q2 2026, an estimated $44.3K.
  • Evolent Health made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5141 holding.
  • Osaic Holdings first reported a position in Evolent Health in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Evolent Health position peaked at $994K in Q1 2022.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.